Benitec Biopharma Ltd ADR (BNTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,857 | 50,929 | 2,490 | 4,076 | 19,784 |
| Receivables | 33 | 229 | 55 | 3 | 25 |
| Other current assets | 628 | 516 | 1,184 | 741 | 799 |
| TOTAL | $98,518 | $51,674 | $3,729 | $4,820 | $20,608 |
| Non-Current Assets | |||||
| PPE Net | 131 | 179 | 87 | 222 | 375 |
| Investments And Advances | 55 | 25 | 25 | 25 | 9 |
| Other Non-Current Assets | 888 | 332 | 623 | 906 | 387 |
| TOTAL | $1,074 | $536 | $735 | $1,153 | $771 |
| Total Assets | $99,592 | $52,210 | $4,464 | $5,973 | $21,379 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,022 | 4,165 | 3,231 | 1,880 | 880 |
| TOTAL | $1,802 | $4,924 | $3,978 | $2,532 | $1,369 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 38 | 0 | 0 | 0 |
| TOTAL | $495 | $38 | $284 | $559 | $N/A |
| Total Liabilities | $2,297 | $4,962 | $4,262 | $3,091 | $1,369 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,250 | 10,556 | 2,547 | 480 | 2 |
| Common Shares | 2 | 1 | N/A | N/A | 1 |
| Retained earnings | -228,176 | -190,259 | -167,889 | -148,327 | -130,119 |
| Other shareholders' equity | -839 | -892 | -830 | -1,245 | -1,455 |
| TOTAL | $97,295 | $47,248 | $202 | $2,882 | $20,010 |
| Total Liabilities And Equity | $99,592 | $52,210 | $4,464 | $5,973 | $21,379 |